ST Innovative Diagnostics
Monitoring Malignancies trough a Simple Blood Test
Active
Seed
Startup
Be'er Ya'akov
Founded 2022-07
ST Innovative Diagnostics developed a novel blood-based malignancy monitoring test, based on research from Rabin Medical Center and Tel Aviv University. The company's proprietary technology & kit, measures Fibrinogen Like Protein 2 (FGL2) activity in platelets, enabling non-invasive disease monitoring and relapse prediction across multiple malignancies. POC…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$70K
Employees2
Founded2022-07
HQBe'er Ya'akov
Patents1
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technology
BiologicalsMoleculesCells
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical EquipmentHealthcarePatientsLaboratories